Diversified Trust Co Cuts Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Diversified Trust Co cut its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 20.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,480 shares of the medical instruments supplier’s stock after selling 371 shares during the quarter. Diversified Trust Co’s holdings in Mettler-Toledo International were worth $1,811,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in MTD. Blue Trust Inc. increased its position in shares of Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in Mettler-Toledo International in the third quarter valued at $37,000. Itau Unibanco Holding S.A. purchased a new stake in Mettler-Toledo International during the 2nd quarter worth about $42,000. Raleigh Capital Management Inc. boosted its position in shares of Mettler-Toledo International by 272.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 30 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Mettler-Toledo International by 60.0% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock valued at $72,000 after acquiring an additional 18 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This represents a 24.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Trading Down 0.8 %

Shares of MTD stock opened at $1,245.45 on Thursday. The company has a market capitalization of $26.28 billion, a P/E ratio of 33.58, a price-to-earnings-growth ratio of 4.21 and a beta of 1.12. The business’s 50 day moving average is $1,254.15 and its two-hundred day moving average is $1,350.79. Mettler-Toledo International Inc. has a twelve month low of $1,122.21 and a twelve month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million for the quarter, compared to analysts’ expectations of $941.93 million. As a group, equities analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on MTD shares. Wolfe Research initiated coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating for the company. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Wells Fargo & Company cut their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their target price for the company from $1,375.00 to $1,450.00 in a research report on Thursday, January 2nd. Finally, Stifel Nicolaus cut their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $1,351.25.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.